Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Fuel cell and a method of manufacturing a fuel cell
Touch screen tablet
Management of temporal data by means of a canonical schema
Method of preparing enteric hard capsule and enteric hard capsule prepared thereby
Vehicle display system or projection display for a motor vehicle, and calibration method
Identification of protected content in e-mail messages
  Randomly Featured Patents
Desktop picture frame support and eyeglass holder
Strain relief IDC connector
Roll of wet wipes
Combined barbeque grill and ring shelf
Network supporting centralized management of QoS policies
Bend/cut-off gauge for a portable sheet bending brake
Power pack
Pressure-contact connector